Michael Abou-Dakn

Prof. Dr. Michael Abou-Dakn

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
EJEsther Jimenez
Esther Jimenez
SMSusana Manzano
Susana Manzano
Dietmar SchlembachDietmar Schlembach
Dietmar Schlembach
KAKrzysztof Arciszewski
Krzysztof Arciszewski
RMRocio Martin
Rocio Martin
PGPREMIUM Study Group
PREMIUM Study Group
Mastitis is considered one of the main reasons for unwanted breastfeeding cessation. This study aimed to investigate the preventive effect of the probiotic strain Ligilactobacillus salivarius PS2 on the occurrence of mastitis in lactating women. In this multicountry, multicenter, randomized, double-blind, placebo-controlled trial, 328 women were assigned to the probiotic or the placebo group. The intervention started from the 35th week of pregnancy until week 12 post-partum. The primary outcome was the incidence (hazard) rate of mastitis, defined as the presence of at least two of the following symptoms: breast pain, breast erythema, breast engorgement not relieved by breastfeeding, and temperature > 38 °C. The probability of being free of mastitis during the study was higher in the probiotic than in the placebo group (p = 0.022, Kaplan–Meier log rank test) with 9 mastitis cases (6%) vs. 20 mastitis cases (14%), respectively. The hazard ratio of the incidence of mastitis between both study groups was 0.41 (0.190–0.915; p = 0.029), indicating that women in the probiotic group were 58% less likely to experience mastitis. In conclusion, supplementation of L. salivarius PS2 during late pregnancy and early lactation was safe and effective in preventing mastitis, which is one of the main barriers for continuing breastfeeding.

5 July 2018 in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Verified
Journal Article
Closed access
PDF file
MAMichael Abou-Dakn
Michael Abou-Dakn

3 November 2022 in Geburtshilfe und Frauenheilkunde
Verified
Journal Article
Closed access
PDF file
MAMichael Abou-Dakn
Michael Abou-Dakn
RSRainhild Schäfers
Rainhild Schäfers
NPNina Peterwerth
Nina Peterwerth
KAKirsten Asmushen
Kirsten Asmushen
SBSusanne Bässler-Weber
Susanne Bässler-Weber
SKSven Kehl
Sven Kehl
Purpose This guideline aims to summarize the current state of knowledge about vaginal birth at term. The guideline focuses on definitions of the physiological stages of labor as well as differentiating between various pathological developments and conditions. It also assesses the need for intervention and the options to avoid interventions. This first part presents recommendations and statements about patient information and counselling, general patient care, monitoring of patients, pain management and quality control measures for vaginal birth.Methods The German recommendations largely reproduce the recommendations of the National Institute for Health and Care Excellence (NICE) CG 190 guideline “Intrapartum care for healthy women and babies”. Other international guidelines were also consulted in specific cases when compiling this guideline. In addition, a systematic search and analysis of the literature was carried out using PICO questions, if this was considered necessary, and other systematic reviews and individual studies were taken into account. For easier comprehension, the assessment tools of the Scottish Intercollegiate Guidelines Network (SIGN) were used to evaluate the quality of the additionally consulted studies. Otherwise, the GRADE system was used for the NICE guideline and the evidence reports of the IQWiG were used to evaluate the quality of the evidence.Recommendations Recommendations and statements were formulated based on identified evidence and/or a structured consensus.

3 November 2022 in Geburtshilfe und Frauenheilkunde
Verified
Journal Article
Closed access
PDF file
MAMichael Abou-Dakn
Michael Abou-Dakn
RSRainhild Schäfers
Rainhild Schäfers
NPNina Peterwerth
Nina Peterwerth
KAKirsten Asmushen
Kirsten Asmushen
SBSusanne Bässler-Weber
Susanne Bässler-Weber
SKSven Kehl
Sven Kehl
Purpose This guideline aims to summarize the current state of knowledge about vaginal birth at term. The guideline focuses on definitions of the physiological stages of labor as well as differentiating between various pathological developments and conditions. It also assesses the need for intervention and the options to avoid interventions. The second part of this guideline presents recommendations and statements on care during the dilation and expulsion stages as well as during the placental/postnatal stage. Methods The German recommendations largely reproduce the recommendations of the National Institute for Health and Care Excellence (NICE) CG190 guideline “Intrapartum care for healthy women and babies”. Other international guidelines were also consulted in individual cases when compiling this guideline. In addition, a systematic search and analysis of the literature was carried out using PICO questions where necessary, and other systematic reviews and individual studies were taken into account. For easier comprehension, the assessment tools of the Scottish Intercollegiate Guidelines Network (SIGN) were used to evaluate the quality of additionally consulted studies. Otherwise, the GRADE system was used for the NICE guideline, and the evidence reports of the IQWiG were used to evaluate the quality of the evidence. Recommendations Recommendations and statements were formulated based on identified evidence and/or a structured consensus.

4 July 2015 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Open access
PDF file
CSChristiane Schwarz
Christiane Schwarz
RSRainhild Schäfers
Rainhild Schäfers
CLChristine Loytved
Christine Loytved
PHPeter Heusser
Peter Heusser
MAMichael Abou-Dakn
Michael Abou-Dakn
BBBettina Berger
Bettina Berger
While a variety of factors may play a role in fetal and neonatal deaths, postmaturity as a cause of stillbirth remains a topic of debate. It still is unclear, whether induction of labor at a particular gestational age may prevent fetal deaths.

1 December 2021 in Neonatology
Verified
Journal Article
Closed access
PDF file
JKJanine Kröger
Janine Kröger
CGChristian Günster
Christian Günster
GHGünther Heller
Günther Heller
EJElke Jeschke
Elke Jeschke
JMJürgen Malzahn
Jürgen Malzahn
CBChristoph Bührer
Christoph Bührer
Background: Low birthweight and major congenital malformations (MCMs) are key causes of infant mortality. Objectives: The aim of this study was to explore the prevalence of MCMs in infants with low and very low birthweight and analyze the impact of MCMs and birthweight on infant mortality. Methods: We determined prevalence and infant mortality of 28 life-threatening MCMs in very-low-birthweight (<1,500 g, VLBW), low-birthweight (1,500–2,499 g, LBW), or normal-birthweight (≥2,500 g, NBW) infants in a cohort of 2,727,002 infants born in Germany in 2006–2017, using de-identified administrative data of the largest statutory public health insurance system in Germany. Results: The rates of VLBW, LBW, and NBW infants studied were 1.3% (34,401), 4.0% (109,558), and 94.7% (2,583,043). MCMs affected 0.5% (13,563) infants, of whom >75% (10,316) had severe congenital heart disease. The prevalence (per 10,000) of any/cardiac MCM was increased in VLBW (286/176) and LBW (244/143), as compared to NBW infants (38/32). Infant mortality rates were significantly higher in infants with an MCM, as opposed to infants without an MCM, in each birthweight group (VLBW 28.5% vs. 11.5%, LBW 16.7% vs. 0.9%, and NBW 8.6% vs. 0.1%). For most MCMs, observed survival rates in VLBW and LBW infants were lower than expected, as calculated from survival rates of VLBW or LBW infants without an MCM, and NBW infants with an MCM. Conclusions: Infants with an MCM are more often born with LBW or VLBW, as opposed to infants without an MCM. Many MCMs carry significant excess mortality when occurring in VLBW or LBW infants.